날짜	액션	분석자	등급 변경
2023-12-04	개시	BofA Securities	Buy
2023-09-19	개시	Citigroup	Neutral
2023-07-21	개시	TD Cowen	Outperform
2023-05-12	다운그레이드	SVB Securities	Outperform → Market Perform
2023-04-26	개시	SMBC Nikko	Outperform
2023-04-12	업그레이드	SVB Securities	Market Perform → Outperform
2023-03-21	개시	Bernstein	Mkt Perform
2022-09-09	개시	Morgan Stanley	Equal-Weight
2022-05-11	업그레이드	Robert W. Baird	Neutral → Outperform
2022-01-19	재개	Goldman	Buy
2021-08-06	재확인	Chardan Capital Markets	Buy
2021-06-04	재개	Robert W. Baird	Neutral
2021-02-05	재확인	H.C. Wainwright	Buy
2020-12-21	다운그레이드	Robert W. Baird	Outperform → Neutral
2020-12-16	개시	UBS	Buy
2020-11-19	개시	Citigroup	Buy
2020-05-13	개시	RBC Capital Mkts	Outperform
2020-05-08	업그레이드	Oppenheimer	Perform → Outperform
2020-04-15	업그레이드	Cantor Fitzgerald	Neutral → Overweight
2020-03-24	업그레이드	SVB Leerink	Underperform → Mkt Perform
2020-03-17	개시	Goldman	Neutral
2020-01-21	개시	SVB Leerink	Underperform
2019-12-13	개시	Oppenheimer	Perform
2019-11-29	재확인	Chardan Capital Markets	Buy
2019-11-27	재확인	B. Riley FBR	Buy
2019-11-25	업그레이드	Robert W. Baird	Neutral → Outperform
2019-10-24	다운그레이드	Robert W. Baird	Outperform → Neutral
2019-10-22	재확인	Chardan Capital Markets	Buy
2019-10-03	개시	Robert W. Baird	Outperform
2018-09-07	업그레이드	B. Riley FBR	Neutral → Buy
2018-09-06	재확인	Chardan Capital Markets	Buy
2018-08-08	재확인	Cantor Fitzgerald	Overweight
2018-07-02	재확인	Chardan Capital Markets	Buy

내부자 거래	관계	날짜	거래	비용	#주식	가치 ($)	#주식 총계
Lu Hongbo	Director	Mar 20 '24	Buy	27.50	1,000	27,500	33,680
Lu Hongbo	Director	Mar 19 '24	Buy	28.00	1,000	28,000	32,680
Lu Hongbo	Director	Mar 18 '24	Buy	27.49	1,000	27,490	31,680
Myszkowski Kenneth Allen	Chief Financial Officer	Mar 06 '24	Sale	35.19	40,000	1,407,600	400,600
Anzalone Christopher Richard	Chief Executive Officer	Jan 31 '24	Option Exercise	14.54	57,499	836,035	3,772,547
Anzalone Christopher Richard	Chief Executive Officer	Jan 31 '24	Sale	32.35	57,499	1,860,019	3,715,048
Hamilton James C	Chief Discovery/Trans Medicine	Jan 12 '24	Sale	36.89	7,940	292,904	210,851
Vakiener Victoria	Director	Jan 11 '24	Sale	38.10	4,720	179,813	32,001
Waddill William D.	Director	Jan 11 '24	Sale	38.07	3,934	149,759	47,870
Ferrari Mauro	Director	Jan 11 '24	Sale	38.06	3,147	119,787	60,778

Arrowhead Pharmaceuticals Inc. (ARWR)

Arrowhead Pharmaceuticals Inc. Stock (ARWR) Company Profile

Arrowhead Pharmaceuticals Inc. Stock (ARWR) Upgrades & Downgrades

Arrowhead Pharmaceuticals Inc. 주식(ARWR)의 최신 뉴스

NetApp, Zoom Video And 2 Other Stocks Insiders Are Selling

EQT, Genie Energy And Other Big Stocks Moving Lower On Monday

Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday

Cracking The Code: Understanding Analyst Reviews For Arrowhead Pharma

Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday

Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Arrowhead Pharmaceuticals Inc. (ARWR) 재무 분석

Arrowhead Pharmaceuticals Inc. (ARWR) 매출 2024

Arrowhead Pharmaceuticals Inc. (ARWR) 순이익 2024

Arrowhead Pharmaceuticals Inc. (ARWR) 현금흐름 2024

Arrowhead Pharmaceuticals Inc. (ARWR) 주당 순이익 2024

Arrowhead Pharmaceuticals Inc. 주식 (ARWR) 내부자 거래

ARWR과 유사한 종목